MTOR and Kaposi's sarcoma: KSHV infection induces mesenchymal transition and loss of contact inhibition [5, 44, 45], which might contribute to the constitutive activation of the mTOR pathway in KSHV-infected cells [46], and hence the susceptibility of KS tumors to rapamycin [47].